2, 3, 4, 5, 6 COVID-19 boosters?

When a Greek-born Doctor of Veterinarian Medicine tells you that a vaccine is coming to America in March to prevent the Omicron version of COVID-19, you would normally respond with "Quack! Quack!" But if that doc is also the CEO of Pfizer - Albert Bourla - you should cringe and realize another jab is coming. … Continue reading 2, 3, 4, 5, 6 COVID-19 boosters?

$12 antivirus drug in India is $712 here!

In November a Food and Drug Administration (FDA) advisory panel is expected to approve the use of a Merck drug to treat the Covid virus. It claims to reduce symptoms and slice the number of hospitalizations. The average Covid hospital stay costs between $34,662 and $45,683, according to a FAIR Health Brief. Most victims today … Continue reading $12 antivirus drug in India is $712 here!

Biden wants Medicare cut to pay for bill that benefits investors and corporations

The government has once again decided to turn on the American people. The latest is a multi-trillion dollar boondoggle - pushed behind the mask of infrastructure improvement - that will just use more of our money to add profits to investors and large companies already rolling in cash. The White House doesn't even attempt to … Continue reading Biden wants Medicare cut to pay for bill that benefits investors and corporations

Weaklings here negotiate drug prices nationally just as poorly as if drug companies did it for them

Does America have a two-tiered health system - one for the entitled and one for the rest of us? When former President Donald Trump contracted Covid-19 just before the 2020 election, his first treatment by doctors was administering Regeneron's antibody cocktail, dubbed REGN-COV2. Trump recovered quickly, and was back to work in less than a … Continue reading Weaklings here negotiate drug prices nationally just as poorly as if drug companies did it for them

Are we paying more than 20 times production cost for the COVID-19 vaccines, thanks to Biden deal?

American taxpayers have bought one billion COVID-19 doses from Pfizer Inc. and partner BioNTech SE. Our government has also purchased 500 million vaccine doses from Moderna. That's enough prevention for two doses to every U.S. resident, plus two jabs to all the citizens of Australia, Austria, Belgium, Bolivia, Burundi, Cambodia, Canada, Chile, Czech Republic, Ecuador, … Continue reading Are we paying more than 20 times production cost for the COVID-19 vaccines, thanks to Biden deal?

Walmart and Walt Disney to take away jobs from some poorly-paid workers who lack Covid-19 jab

The Walt Disney Company announced Friday that all employees - working for the company in the United States - must be vaccinated against the Communist Chinese Party (CCP) COVID virus. Disney joins big-tech companies, including Google and Facebook, who declared in July that every American employee must get the jab before entering the office. The … Continue reading Walmart and Walt Disney to take away jobs from some poorly-paid workers who lack Covid-19 jab

House weasel Scott Peters voted for hopeless bill to cut drug prices, but was just faking it for votes

Millions of Americans have died because they couldn't afford to pay for prescription drugs that might have saved their lives, and millions more stay in horrible jobs just to hold on to company/worker sickness insurance. How the dangerous gamble to not take an expensive drug evolves: You don't have health insurance and are diagnosed with … Continue reading House weasel Scott Peters voted for hopeless bill to cut drug prices, but was just faking it for votes

Foreign laboratories and factories dominate American drug market, while FDA flounders

If you thought the American people were the customers of the U.S. Food and Drug Administration (FDA), you were wrong Human Drugs regulatory activities account for 33 percent of FDA’s budget; 65 percent of these activities are paid for by industry user fees, boasts the FDA website. No surprise: the 15,000 employees of the FDA … Continue reading Foreign laboratories and factories dominate American drug market, while FDA flounders